Health Care

Twenty-five new genetic mutations were found in people with sporadic ALS but not in their parents, supporting the role of genetic contribution in the noninherited form of the disease

Posted on Friday, May 31, 2013 - 12:00, By: Amy Madsen
A team of researchers in the U.S. and Australia has shed new light on sporadic amyotrophic lateral sclerosis (ALS), finding that some people with the disorder have gene mutations that may be associated with ALS and that do not exist in either of their parents — so-called de novo mutations.

Newest clinic to be designated an MDA/ALS center is located at Louisiana State University (LSU) Health Sciences Center New Orleans School of Medicine

Posted on Tuesday, May 21, 2013 - 05:00, By: Amy Madsen
The Muscular Dystrophy Association has designated the MDA clinic at Louisiana State University Health Sciences Center School of Medicine in New Orleans as an MDA/ALS center. This brings the total number of these specialized clinics to 44.

A 500,000-person European study finds that underweight individuals have a significantly increased risk of ALS

Posted on Monday, February 18, 2013 - 05:00, By: Amy Madsen
Anecdotal evidence has long described a positive association between being lean or underweight and developing amyotrophic lateral sclerosis (ALS). Now, results from a large-scale study conducted in Europe appear to confirm these observations, showing that individuals with more body fat have a...

Amorfix Life Sciences is developing a blood test designed to detect and measure misfolded SOD1 protein, which is thought to play a role ALS

Posted on Friday, February 1, 2013 - 11:44, By: Amy Madsen
Development is under way of a blood test that may help doctors rule in or rule out a diagnosis of amyotrophic lateral sclerosis (ALS).

Eligible individuals with a diagnosis of pseudobulbar affect (uncontrolled laughing or crying) now can gain free or low-cost access to a drug that treats it

Posted on Friday, June 8, 2012 - 02:26, By: Amy Madsen
A new Patient Assistance Program can help people with a diagnosis of pseudobulbar affect (PBA) get a medication designed to treat the condition at low or no cost.

'Best practices' for treating amyotrophic lateral sclerosis (ALS) were among the presentations at MDA’s 2012 Clinical Conference, held in March

Posted on Friday, April 20, 2012 - 14:07, By: Margaret Wahl
Several experts presented their views of best practices for care of people with ALS at MDA's 2012 Clinical Conference, held in Las Vegas March 4-7. Best practices outlined in this article include:

ALS research update on findings related to abnormal functioning of mitochondria, cellular energy production and metabolism

Posted on Friday, February 24, 2012 - 15:01, By: Amy Madsen
Below are highlights of two recent studies in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease).